Committee & streams

The programme of the IDF World Diabetes Congress 2022 is organised across eight streams.

Basic and Translational 
Science (BTS)
Lead
Paula Macedo
Portugal
Members
Young-Bum Kim
USA
Norbert Stefan
Germany
Sung Hee Choi
South Korea
Clinical, Therapeutic
and Technology
Research (CTT)
Lead
Shashank Joshi
India
Members
David Klonoff
USA
Chantal Mathieu
Belgium
Pablo Aschner Monotoya
Columbia
Diabetes Complications
and Comorbidities (DCC)
Lead
Andrea Luk
China
Members
Kamlesh Khunti
United Kingdom
David Preiss
United Kingdom
George King
USA
Health Services and
Policy (HSP)
Lead
Niti Pall
United Kingdom
Members
Partha Kar
United Kingdom
Cajsa Lindberg
Sweden
Reem Fahd Al Bunyan
Kingdom of Saudi Arabia
Diabetes in Women (DIW)
Lead
Maria Inês Schmidt
Brazil
Members
Usha Siriam
India
Caroline Kramer
Canada
David Simmons
Australia
Education and
Integrated Care (EIC)
Lead
Zilin Sun
China
Members
Rajata Rajatanavin
Thailand
Tatjana Milenkovic
Macedonia
Edwin B Fisher
USA
Epidemiology and
Public Health (EPH)
Lead
Ayesha Motala
South Africa
Members
Elizabeth Selvin
USA
Edward Gregg
United Kingdom
Abdul Basit
Pakistan
Living with Diabetes (LWD)
Lead
Sana Ajmal
Pakistan
Members
Georgina Peters
Australia
Sebastian Hauck
Germany
Mila Clarke Buckley
USA

Programme Chair: Jonathan Shaw, Australia

Jonathan Shaw MD, FRCP (UK), FRACP,FAAHMS is Deputy Director at Melbourne’sBaker Heart and Diabetes Institute. He is also an endocrinologist, Chair of the DiabetesAdvisory Group to the Australian Institute ofHealth and Welfare (AIHW), Council Memberof the Australian Diabetes Society, andPast-President of the International DiabetesEpidemiology Group (IDEG). His awards include theIDEG Peter Bennett Award(2011), the Australian Diabetes Society (ADS) Jeff Flack Diabetes DataAward (2015), and the ADS Kellion Diabetes Award (2018). He hasauthored more than 400 peer-reviewed scientific papers and 35 bookchapters, and was included in the Thomson Reuters The World’s MostInfluential Scientific Minds (2014), and the Clarivate Analytics list of theworld’s most Highly Cited Researchers (2017 and 2018). His areas ofinterest include epidemiology and clinical trials in diabetes.

Vice Chair: João Valente Nabais, Portugal

João Valente Nabais PhD is AssistantProfesor with Habilitation at the University ofEvora (Portugal). Diagnosed with type 1diabetes in 1981, João has been activelyinvolved in diabetes at the national and international level. Hehas been involved in diabetes camps andthe development of educational courses forpeople with diabetes and parents ofchildren with diabetes, and oversaw the launch of the IDF EuropeYouth Leadership Camp. João is a member of the ComprehensiveHealth Research Center and a consultant to the Portuguese DiabetesAssociation (APDP). He is a Past President of the IDF European Region(2012-15) and currently a Vice-President of IDF. He has published 60papers in international journals, participated in 15 R&D projects asResearcher and is the co-author of 3 patents.

STREAM LEADS

Basic and Translational Science: Paula Macedo

Paula Macedo is currently Professor at theNOVA Medical School, NOVA University inLisbon, and at the Department of MedicalSciences Universidade Aveiro, Portugal.Professor Macedo graduated in Pharmacyfrom the Faculty of Pharmacy at theUniversity of Lisbon and obtained her PhDfrom the Department of Pharmacology andTherapeutics at the University of Manitoba,Canada. She is the principal investigator of the MEDIR group based atCEDOC NOVA Medical School. Professor Macedo has been awarded several grants as a principalinvestigator on her preferred research subjects in both basic andclinical research. She has been working in research areas relatedto hepatic vasculature and hepatic control of insulin sensitivity.Her significant contributions include the description and explanationof meal-induced insulin action sensitization in prediabetes and diabetes-related pathologies.

Diabetes Complications and Comorbidities : Andrea Luk

Andrea Luk is currently Associate Professor of the Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong. She is also the Medical Director (Non-Oncology) of the Phase 1 Clinical Trial Centre and serves as an honorary associate consultant at the Prince of Wales Hospital. Dr Luk completed her specialist training in endocrinology, reproduction and metabolism in 2007. Her research interests include epidemiology of diabetes and diabetes-relatedcomplications, study of the aetiology and mechanisms of young-onset diabetes, as well as translational studies of care models in people with diabetes.

Diabetes in Women: Maria Inês Schmidt

Maria Inês Schmidt MD, PhD is anendocrinologist and epidemiologist trainedat John Hopkins Hospital and theUniversity of North Carolina. She is Professor atthe School of Medicine of the FederalUniversity of Rio Grande do Sul, Brazilwhere she teaches medical students andgraduate students in epidemiology. Hermain research focuses on the epidemiology oftype 2 diabetes, obesity, gestational diabetes, and diabetes preventionin women. Current main projects include: LINDA Brasil, a randomizedcontrolled trial for the prevention of diabetes in women with recentgestational diabetes; ELSA-Brasil, a cohort study of 15105 Brazilianadults now followed-up for 10 years; Surveillance of diabetes and itscomplications in Brazil; and the Global Burden of Disease (GBD)project. Over the years, she has contributed to the development of IDFguidelines and acted as a panel member on various WHOconsultations related to diabetes. She is a member of the LancetCommission on Diabetes.

Education and Integrated Care: Zilin Sun

Zilin Sun M.D., Ph.D., is Professor ofMedicine and Director of the Institute ofDiabetes at Southeast University, Nanjing,China. Dr. Sun received his doctoral trainingsin Clinical Pharmacology and ClinicalMedicine from China PharmaceuticalUniversity and Ulm University in Germany.He is currently Chair of the ChineseAssociation of Diabetes and Microcirculationand a Committee Member of the Chinese Society of Endocrinology.He was previously Vice Director of the Diabetes Education andManagement Group of the Chinese Diabetes Society, a Committee member of Chinese Diabetes Society and Chair of the Jiangsu Diabetes Society. Dr. Sun is on the editorialboard of “BMC Med” and “Diabetes Metab J” and has published morethan 200 scientific papers, including more than 100 SCI-indexedpublications.

Epidemiology and Public Health: Ayesha Motala

Ayesha Motala is a specialist physicianand currently Professor and Clinical Head inthe Department of Diabetes andEndocrinology at Inkosi Albert LuthuliCentral Hospital affiliated to the Nelson R.Mandela School of Medicine, University ofKwaZulu-Natal, Durban, South Africa.Her research hasfocussed on the epidemiology, genetic and clinical aspects of diabetesand other non-communicable diseases (NCDs). She has been involvedin several large-scale population studies, both cross-sectional andlongitudinal, on the epidemiology of diabetes in African (black) andAsian Indian communities in KwaZulu Natal.She is the lead principal investigator of a large consortium-wide studyat 10 sites across 7 countries in sub-Saharan Africa - the HumanHereditary and Health in Africa (H3Africa) study on diabetes, fundedthrough the Wellcome Trust.

Living with Diabetes: Sana Ajmal

Sana Ajmal is a seasoned diabetesadvocate, with years of experience withvarious IDF programmes and activities,including Young Leaders in Diabetes,the Diabetes Education Consultative Section and the IDF Congress.She is the Founder and Executive Director ofMeethi Zindagi, the only national,people-centric, non-profit organization in Pakistan providingpsychosocial support, peer education and medicines to the diabetescommunity. Herdistinction lies in tailoring international best practices to a localperspective and simplifying complex solutions with an engineeredapproach and technology to create robust systems and services inresource-limited settings.

Clinical, Therapeutic and Technology Research: Shashank Joshi

Shashank R. Joshi is the Chair of the IDFSoutheast Asian Region and Dean ofthe Indian College of Physicians fromMumbai, India. He is Past President of theEndocrine Society of India, RSSDI and manyother societies in India and Asia. He is a well-known endocrinologist attached toJoshi Clinic and Lilavati Hospital and haspublished more than 800 publications andwritten 100 books. His areas of interest include diabetes and obesity therapy and developing low-cost interventions forthe developing world.

Health Services and Policy: Niti Pall

Niti Pall is President of IDF Europe. She isGlobal Medical Director for KPMG andSenior Mobile Health Advisor for AXA. Shealso sits on the board of the BirminghamWomen’s and Children’s Hospital.Niti is a senior Doctor who has deepexpertise in primary care models and healthbenefit management across the world.Niti helped to build up the largest chainof primary care clinics in the UK – the Modality Partnership – andheld several senior commissioning roles in the English NHS. She hasinnovated with new extended primary care and enhanced primarycare including diabetes care across the world. Her interest in diabetesspans three decades, starting when her son was diagnosed with type 1 diabetes. She is passionate about involving patients in driving good quality services.

Learning objectives

Basic and Translational Science (BTS)

Clinical, Therapeutic and
Technology Research (CTT)

Diabetes Complications and
Comorbidities (DCC)

Diabetes in Women (DIW)

Education and Integrated Care (EIC)

Epidemiology and Public Health (EPH)

Health Services and Policy (HSP)

Living with Diabetes (LWD)

This stream addresses recent progress in diabetes research and its future applications in diabetes care as well as the latest advances in science-based clinical practice.

This stream deals with current and future areas of clinical therapeutics, diabetes technology and future research direction.

This stream deals with current and future areas of clinical therapeutics, diabetes technology and future research direction.

This stream will focus on the best evidence to treat and prevent diabetes and related conditions among women, including hyperglycaemia in pregnancy (HIP) and its long-term effects on
mother and child.

This stream focuses on all aspects related to diabetes education and diabetes self-management and support, with a particular interest on diabetes care delivered by healthcare providers, peers, families, or communities, as well as on diabetes management systems/models integrated with tools dealing with diabetes detection, glucose monitoring, diet, or physical activity.

This stream deals with updates on recent research and advances on the epidemiology of diabetes diagnosis, complications and prevention, the public health challenges being faced and how to prevent and deal with them.

This stream will focus on health systems and policies that affect diabetes care, and most importantly people living with diabetes. There will be a focus on both the wider funding of healthcare in general,
and on policies that impact diabetes care at a micro and macro level.

The stream gives an in-depth insight into the perspectives of people living with diabetes and highlights their role in diabetes awareness, prevention, education, support, advocacy and communication.

Share on facebook
Share
Share on twitter
Share
Share on linkedin
Share